MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $119,267 | -6.1% | 16,704 | +0.2% | 0.00% | – |
| Q3 2022 | $127,000 | +47.7% | 16,669 | -0.4% | 0.00% | – |
| Q2 2022 | $86,000 | -98.2% | 16,737 | -98.6% | 0.00% | -100.0% |
| Q1 2022 | $4,665,000 | +427.1% | 1,157,635 | +2004.4% | 0.00% | +100.0% |
| Q1 2021 | $885,000 | +486.1% | 55,011 | +567.4% | 0.00% | – |
| Q4 2020 | $151,000 | +228.3% | 8,243 | +233.6% | 0.00% | – |
| Q3 2020 | $46,000 | -97.8% | 2,471 | -97.4% | 0.00% | -100.0% |
| Q2 2020 | $2,116,000 | +8038.5% | 93,663 | +1953.6% | 0.00% | – |
| Q4 2019 | $26,000 | +420.0% | 4,561 | +43.5% | 0.00% | – |
| Q3 2019 | $5,000 | -58.3% | 3,179 | +5.3% | 0.00% | – |
| Q2 2019 | $12,000 | +1100.0% | 3,019 | +1605.6% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 177 | +103.4% | 0.00% | – |
| Q3 2018 | $1,000 | -80.0% | 87 | -69.3% | 0.00% | – |
| Q2 2018 | $5,000 | +66.7% | 283 | +45.1% | 0.00% | – |
| Q1 2018 | $3,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |